PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,265,898 | -30.6% | 2,929,903 | -11.9% | 0.09% | -32.3% |
| Q2 2023 | $43,604,712 | +26.5% | 3,326,065 | +7.9% | 0.13% | +21.5% |
| Q1 2023 | $34,470,735 | +131.9% | 3,083,250 | +74.9% | 0.11% | +109.8% |
| Q4 2022 | $14,865,108 | +69.4% | 1,763,358 | +234.7% | 0.05% | +45.7% |
| Q3 2022 | $8,776,000 | +51.5% | 526,797 | +33.8% | 0.04% | +45.8% |
| Q2 2022 | $5,794,000 | +236.5% | 393,600 | +467.1% | 0.02% | +242.9% |
| Q1 2022 | $1,722,000 | -83.1% | 69,400 | -78.2% | 0.01% | -82.9% |
| Q4 2021 | $10,195,000 | +12.8% | 317,907 | +26.6% | 0.04% | +2.5% |
| Q3 2021 | $9,038,000 | -69.0% | 251,200 | -62.0% | 0.04% | -69.5% |
| Q2 2021 | $29,155,000 | +95.3% | 660,801 | +102.5% | 0.13% | +87.1% |
| Q1 2021 | $14,926,000 | +165.0% | 326,313 | +299.9% | 0.07% | +159.3% |
| Q4 2020 | $5,632,000 | – | 81,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $10,278,050 | 5.54% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $621,907 | 2.98% |
| PURA VIDA INVESTMENTS, LLC | 726,298 | $7,502,658 | 1.42% |
| CFM WEALTH PARTNERS LLC | 264,039 | $2,727,523 | 0.71% |
| BRAIDWELL LP | 988,559 | $10,211,814 | 0.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,017,958 | $10,515,506 | 0.23% |
| Rock Springs Capital Management LP | 652,400 | $6,739,292 | 0.18% |
| Point72 Asset Management, L.P. | 2,929,903 | $30,265,898 | 0.09% |
| ALGERT GLOBAL LLC | 117,327 | $1,212 | 0.06% |
| Campbell & CO Investment Adviser LLC | 45,380 | $468,775 | 0.06% |